Global Herpes Treatment Market 2017-2021

Publisher Name :
Date: 14-Jun-2017
No. of pages: 82
Price : Single User: US $ 3500  US $ 2500 Corporate User: US $ 5000  US $ 4000
Inquire Before Buying
Avail $1000 Discount on this report till 31st December, 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Herpesviruses belong to double-stranded DNA viruses, which are responsible for a large number of diseases in humans and animals. There are eight types of human herpesvirus (HHV) that affects humans. Among these, herpes simplex virus (HSV) and varicella-zoster virus (VZV) are the two most commonly found HHVs that causes severe infections in humans. HSV is further segmented into oral herpes and genital herpes.

The analysts forecast global herpes treatment market to grow at a CAGR of 12.97% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global herpes treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs in herpes treatment market.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Herpes Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • Gilead

  • GlaxoSmithKline

  • Merck

  • Novartis


Other prominent vendors


  • Abbott

  • Agenus

  • Genocea

  • Mylan

  • Teva Pharmaceutical Industries

  • Vical


Market driver


  • Increasing prevalence of herpes infection

  • For a full, detailed list, view our report


Market challenge


  • Side effects of drugs

  • For a full, detailed list, view our report


Market trend


  • Emergence of novel therapies

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Avail $1000 Discount on this report till 31st December, 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Herpes Treatment Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Market outline
Disease overview

PART 05: Market introduction
Market overview
Market size and forecast
Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by virus type
Herpes simplex
Herpes zoster

PART 08: Geographical segmentation
Herpes treatment market in Americas
Herpes treatment market in EMEA
Herpes treatment market in APAC

PART 09: Key leading count

PART 10: Drivers and challenges
Market drivers
Market challenges

PART 11: Market trends
Emergence of novel therapies
Increasing focus on vaccine development
Increasing focus on drug development for pre-adolescent patients

PART 12: Vendor landscape
Competitive scenario

PART 13: Key vendor analysis
Gilead
GlaxoSmithKline
Merck
Novartis
Other prominent vendors

PART 14: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Types of HHV
Exhibit 02: Symptoms of herpesvirus infection
Exhibit 03: Diagnosis and treatment of herpes
Exhibit 04: Global herpes treatment market snapshot
Exhibit 05: Global herpes treatment market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis: Global herpes treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Key pipeline molecules by vendors
Exhibit 09: Key clinical trials
Exhibit 10: Global herpes treatment market by virus type
Exhibit 11: Global HSV treatment market
Exhibit 12: Market overview: Global HSV treatment market
Exhibit 13: Global oral herpes treatment market 2016-2021 ($ millions)
Exhibit 14: Global share of HSV-2 infection
Exhibit 15: Global genital herpes treatment market 2016-2021 ($ millions)
Exhibit 16: Global herpes zoster treatment market 2016-2021 ($ millions)
Exhibit 17: Segmentation of global herpes treatment market by geography 2016 and 2021
Exhibit 18: Global herpes treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Herpes treatment market in Americas 2016-2021 ($ millions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Herpes treatment market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market scenario of APAC
Exhibit 24: Herpes treatment market in APAC 2016-2021 ($ millions)
Exhibit 25: Population at a higher risk of herpes
Exhibit 26: Percentage distribution of organ transplants in US 1988-2016
Exhibit 27: Competitive structure analysis of global herpes treatment market 2016
Exhibit 28: Strategic success factors of companies in global herpes treatment market
Exhibit 29: Gilead: Key highlights
Exhibit 30: Gilead: Strength assessment
Exhibit 31: Gilead: Strategy assessment
Exhibit 32: Gilead: Opportunity assessment
Exhibit 33: GlaxoSmithKline: Key highlights
Exhibit 34: GlaxoSmithKline: Strength assessment
Exhibit 35: GlaxoSmithKline: Strategy assessment
Exhibit 36: GlaxoSmithKline: Opportunity assessment
Exhibit 37: Merck: Key highlights
Exhibit 38: Merck: Strength assessment
Exhibit 39: Merck: Strategy assessment
Exhibit 40: Merck: Opportunity assessment
Exhibit 41: Novartis: Key highlights
Exhibit 42: Novartis: Strength assessment
Exhibit 43: Novartis: Strategy assessment
Exhibit 44: Novartis: Opportunity assessment

  • Global Polymixin Sales Market Report 2017
    Published: 16-Oct-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the global Polymixin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Polymixin for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeast As......
  • Global and Regional Drugs For Herpes Labialis (Oral Herpes) Market Research Report 2017
    Published: 13-Oct-2017        Price: US 3500 Onwards        Pages: 137
    Summary Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2-3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original......
  • Global Metronidazole Market Professional Survey Report 2017
    Published: 13-Oct-2017        Price: US 3500 Onwards        Pages: 103
    This report studies Metronidazole in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Hayao - Renhe Pharmacy - Hongda Pharmaceutical - Topsun Pharmaceutical......
  • Global Aspergillosis Drugs Market Research Report 2017
    Published: 11-Oct-2017        Price: US 2900 Onwards        Pages: 117
    In this report, the global Aspergillosis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Aspergillosis Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global Drugs for Clostridium Difficile Infections Market Professional Survey Report 2017
    Published: 11-Oct-2017        Price: US 3500 Onwards        Pages: 127
    This report studies Drugs for Clostridium Difficile Infections in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Absynth Biologics Limited - Actelion - Adenium B......
  • Global Ampicillin Market Research Report 2017
    Published: 11-Oct-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Ampicillin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Ampicillin in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • United States Meningococcal Infections Vaccine Market Report 2017
    Published: 10-Oct-2017        Price: US 3800 Onwards        Pages: 96
    In this report, the United States Meningococcal Infections Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Meningococcal Infections Vaccine Sales Market Report 2017
    Published: 06-Oct-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Meningococcal Infections Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K doses), revenue (Million USD), market share and growth rate of Meningococcal Infections Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • Global Cefazolin Sodium Sales Market Report 2017
    Published: 06-Oct-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the global Cefazolin Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cefazolin Sodium for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs